<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36834984</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>17</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Feb</Month><Day>10</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Role of the MicroRNAs in the Pathogenic Mechanism of Painful Symptoms in Long COVID: Systematic Review.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">3574</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms24043574</ELocationID><Abstract><AbstractText>The ongoing pandemic of COVID-19 has caused more than 6.7 million tragic deaths, plus, a large percentage of people who survived it present a myriad of chronic symptoms that last for at least 6 months; this has been named as long COVID. Some of the most prevalent are painful symptoms like headache, joint pain, migraine, neuropathic-like pain, fatigue and myalgia. MicroRNAs are small non-coding RNAs that regulate genes, and their involvement in several pathologies has been extensively shown. A deregulation of miRNAs has been observed in patients with COVID-19. The objective of the present systematic review was to show the prevalence of chronic pain-like symptoms of patients with long COVID and based on the expression of miRNAs in patients with COVID-19, and to present a proposal on how they may be involved in the pathogenic mechanisms of chronic pain-like symptoms. A systematic review was carried out in online databases for original articles published between March 2020 to April 2022; the systematic review followed the PRISMA guidelines, and it was registered in PROSPERO with registration number CRD42022318992. A total of 22 articles were included for the evaluation of miRNAs and 20 regarding long COVID; the overall prevalence of pain-like symptoms was around 10 to 87%, plus, the miRNAs that were commonly up and downregulated were miR-21-5p, miR-29a,b,c-3p miR-92a,b-3p, miR-92b-5p, miR-126-3p, miR-150-5p, miR-155-5p, miR-200a, c-3p, miR-320a,b,c,d,e-3p, and miR-451a. The molecular pathways that we hypothesized to be modulated by these miRNAs are the IL-6/STAT3 proinflammatory axis and the compromise of the blood-nerve barrier; these two mechanisms could be associated with the prevalence of fatigue and chronic pain in the long COVID population, plus they could be novel pharmacological targets in order to reduce and prevent these symptoms.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Reyes-Long</LastName><ForeName>Samuel</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Basic Neurosciences, Instituto Nacional de Rehabilitaci&#xf3;n LGII, Mexico City 14389, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cort&#xe9;s-Altamirano</LastName><ForeName>Jose Luis</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Basic Neurosciences, Instituto Nacional de Rehabilitaci&#xf3;n LGII, Mexico City 14389, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Department, Universidad Estatal del Valle de Ecatepec, Ecatepec de Morelos 55210, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bandala</LastName><ForeName>Cindy</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Basic Neurosciences, Instituto Nacional de Rehabilitaci&#xf3;n LGII, Mexico City 14389, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Escuela Superior de Medicina, Instituto Polit&#xe9;cnico Nacional, Mexico City 11340, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Avenda&#xf1;o-Ortiz</LastName><ForeName>Karina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Basic Neurosciences, Instituto Nacional de Rehabilitaci&#xf3;n LGII, Mexico City 14389, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonilla-Jaime</LastName><ForeName>Herlinda</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-7505-0809</Identifier><AffiliationInfo><Affiliation>Reproductive Biology Department, Universidad Aut&#xf3;noma Metropolitana, Mexico City 09340, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bueno-Nava</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Basic Neurosciences, Instituto Nacional de Rehabilitaci&#xf3;n LGII, Mexico City 14389, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xc1;vila-Luna</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Basic Neurosciences, Instituto Nacional de Rehabilitaci&#xf3;n LGII, Mexico City 14389, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xe1;nchez-Aparicio</LastName><ForeName>Pedro</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Pharmacology Department, Facultad de Medicina Veterinaria, Universidad Aut&#xf3;noma del Estado de M&#xe9;xico, Toluca 56900, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clavijo-Cornejo</LastName><ForeName>Denise</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Divisi&#xf3;n de Reumatolog&#xed;a, Instituto Nacional de Rehabilitaci&#xf3;n LGII, Mexico City 14389, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dotor-LLerena</LastName><ForeName>Ana Lilia</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Neurociencias Cl&#xed;nicas, Instituto Nacional de Rehabilitaci&#xf3;n LGII, Mexico City 14389, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cabrera-Ruiz</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Basic Neurosciences, Instituto Nacional de Rehabilitaci&#xf3;n LGII, Mexico City 14389, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alfaro-Rodr&#xed;guez</LastName><ForeName>Alfonso</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Basic Neurosciences, Instituto Nacional de Rehabilitaci&#xf3;n LGII, Mexico City 14389, Mexico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059350" MajorTopicYN="Y">Chronic Pain</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="Y">MicroRNAs</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">IL-6/STAT3</Keyword><Keyword MajorTopicYN="N">blood&#x2013;nerve barrier</Keyword><Keyword MajorTopicYN="N">fatigue</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">microRNAs</Keyword><Keyword MajorTopicYN="N">pain</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>2</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>25</Day><Hour>2</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36834984</ArticleId><ArticleId IdType="pmc">PMC9963913</ArticleId><ArticleId IdType="doi">10.3390/ijms24043574</ArticleId><ArticleId IdType="pii">ijms24043574</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lythgoe M.P., Middleton P. Ongoing Clinical Trials for the Management of the COVID-19 Pandemic. Trends Pharmacol. Sci. 2020;41:363&#x2013;382. doi: 10.1016/j.tips.2020.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2020.03.006</ArticleId><ArticleId IdType="pmc">PMC7144665</ArticleId><ArticleId IdType="pubmed">32291112</ArticleId></ArticleIdList></Reference><Reference><Citation>Ndwandwe D., Wiysonge C.S. COVID-19 Vaccines. Curr. Opin. Immunol. 2021;71:111&#x2013;116. doi: 10.1016/j.coi.2021.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2021.07.003</ArticleId><ArticleId IdType="pmc">PMC8272971</ArticleId><ArticleId IdType="pubmed">34330017</ArticleId></ArticleIdList></Reference><Reference><Citation>Razai M.S., Chaudhry U.A.R., Doerholt K., Bauld L., Majeed A. COVID-19 Vaccination Hesitancy. BMJ. 2021;373:n1138. doi: 10.1136/bmj.n1138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1138</ArticleId><ArticleId IdType="pubmed">34016653</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-Acute COVID-19 Syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T., Pinto Pereira S.M., Shafran R., de Stavola B.L., Rojas N., McOwat K., Simmons R., Zavala M., O&#x2019;Mahoney L., Chalder T., et al. Physical and Mental Health 3 Months after SARS-CoV-2 Infection (Long COVID) among Adolescents in England (CLoCk): A National Matched Cohort Study. Lancet Child Adolesc. Health. 2022;6:230&#x2013;239. doi: 10.1016/S2352-4642(22)00022-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(22)00022-0</ArticleId><ArticleId IdType="pmc">PMC8820961</ArticleId><ArticleId IdType="pubmed">35143770</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru S., Merad M. Pathological Sequelae of Long-Haul COVID. Nat. Immunol. 2022;23:194&#x2013;202. doi: 10.1038/s41590-021-01104-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01104-y</ArticleId><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. More than 50 Long-Term Effects of COVID-19: A Systematic Review and Meta-Analysis. Sci. Rep. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major Findings, Mechanisms and Recommendations. Nat. Rev. Microbiol. 2023;13:1&#x2013;14. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Iadecola C., Anrather J., Kamel H. Effects of COVID-19 on the Nervous System. Cell. 2020;183:16&#x2013;27.e1. doi: 10.1016/j.cell.2020.08.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.08.028</ArticleId><ArticleId IdType="pmc">PMC7437501</ArticleId><ArticleId IdType="pubmed">32882182</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig A.M. Chronic Long-COVID Syndrome: A Protracted COVID-19 Illness with Neurological Dysfunctions. CNS Neurosci. Ther. 2021;27:1433&#x2013;1436. doi: 10.1111/cns.13737.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.13737</ArticleId><ArticleId IdType="pmc">PMC8611765</ArticleId><ArticleId IdType="pubmed">34626096</ArticleId></ArticleIdList></Reference><Reference><Citation>Haidar M.A., Jourdi H., Haj Hassan Z., Ashekyan O., Fardoun M., Wehbe Z., Maaliki D., Wehbe M., Mondello S., Abdelhady S., et al. Neurological and Neuropsychological Changes Associated with SARS-CoV-2 Infection: New Observations, New Mechanisms. Neuroscientist. 2021;28:107385842098410. doi: 10.1177/1073858420984106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1073858420984106</ArticleId><ArticleId IdType="pubmed">33393420</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson B.A., Betteridge S., Fish J. Neuropsychological Consequences of COVID-19. Neuropsychol. Rehabil. 2020;30:1625&#x2013;1628. doi: 10.1080/09602011.2020.1808483.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09602011.2020.1808483</ArticleId><ArticleId IdType="pubmed">32869697</ArticleId></ArticleIdList></Reference><Reference><Citation>Galv&#xe1;n-Tejada C.E., Herrera-Garc&#xed;a C.F., Godina-Gonz&#xe1;lez S., Villagrana-Ba&#xf1;uelos K.E., Amaro J.D.D.L., Herrera-Garc&#xed;a K., Rodr&#xed;guez-Qui&#xf1;ones C., Zanella-Calzada L.A., Ram&#xed;rez-Barranco J., de Avila J.L.R., et al. Persistence of COVID-19 Symptoms after Recovery in Mexican Population. Int. J. Environ. Res. Public Health. 2020;17:9367. doi: 10.3390/ijerph17249367.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph17249367</ArticleId><ArticleId IdType="pmc">PMC7765113</ArticleId><ArticleId IdType="pubmed">33327641</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandala C., Cortes-Altamirano J.L., Reyes-Long S., Lara-Padilla E., Ilizaliturri-Flores I., Alfaro-Rodr&#xed;guez A. Putative Mechanism of Neurological Damage in COVID-19 Infection. Acta Neurobiol. Exp. 2021;81:69&#x2013;79. doi: 10.21307/ane-2021-008.</Citation><ArticleIdList><ArticleId IdType="doi">10.21307/ane-2021-008</ArticleId><ArticleId IdType="pubmed">33949163</ArticleId></ArticleIdList></Reference><Reference><Citation>Bulfamante G., Chiumello D., Canevini M.P., Priori A., Mazzanti M., Centanni S., Felisati G. First Ultrastructural Autoptic Findings of SARS-CoV-2 in Olfactory Pathways and Brainstem. Minerva Anestesiol. 2020;86:S0375&#x2013;S9393. doi: 10.23736/S0375-9393.20.14772-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/S0375-9393.20.14772-2</ArticleId><ArticleId IdType="pubmed">32401000</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y.H., Jiang D., Huang J.T. SARS-CoV-2 Detected in Cerebrospinal Fluid by PCR in a Case of COVID-19 Encephalitis. Brain Behav. Immun. 2020;87:149. doi: 10.1016/j.bbi.2020.05.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.05.012</ArticleId><ArticleId IdType="pmc">PMC7202824</ArticleId><ArticleId IdType="pubmed">32387508</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilczynska A., Bushell M. The Complexity of MiRNA-Mediated Repression. Cell Death Differ. 2015;22:22&#x2013;33. doi: 10.1038/cdd.2014.112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2014.112</ArticleId><ArticleId IdType="pmc">PMC4262769</ArticleId><ArticleId IdType="pubmed">25190144</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyes-Long S., Cortes-Altamirano J.L., Clavijio-Cornejo D., Guti&#xe9;rrez M., Bertolazzi C., Bandala C., Pineda C., Alfaro-Rodr&#xed;guez A. Nociceptive Related MicroRNAs and Their Role in Rheumatoid Arthritis. Mol. Biol. Rep. 2020;47:7265&#x2013;7272. doi: 10.1007/s11033-020-05700-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-020-05700-3</ArticleId><ArticleId IdType="pubmed">32740794</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Peng R., Wang J., Qin Z., Xue L. Circulating MicroRNAs as Potential Cancer Biomarkers: The Advantage and Disadvantage. Clin. Epigenet. 2018;10:59. doi: 10.1186/s13148-018-0492-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13148-018-0492-1</ArticleId><ArticleId IdType="pmc">PMC5913875</ArticleId><ArticleId IdType="pubmed">29713393</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsui M., Corey D.R. Non-Coding RNAs as Drug Targets. Nat. Rev. Drug Discov. 2017;16:167&#x2013;179. doi: 10.1038/nrd.2016.117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd.2016.117</ArticleId><ArticleId IdType="pmc">PMC5831170</ArticleId><ArticleId IdType="pubmed">27444227</ArticleId></ArticleIdList></Reference><Reference><Citation>Moszy&#x144;ska A., Gebert M., Collawn J.F., Bartoszewski R. SNPs in MicroRNA Target Sites and Their Potential Role in Human Disease. Open Biol. 2017;7:170019. doi: 10.1098/rsob.170019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsob.170019</ArticleId><ArticleId IdType="pmc">PMC5413909</ArticleId><ArticleId IdType="pubmed">28381629</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig A.M. Chronic COVID Syndrome: Need for an Appropriate Medical Terminology for Long-COVID and COVID Long-haulers. J. Med. Virol. 2021;93:2555&#x2013;2556. doi: 10.1002/jmv.26624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26624</ArticleId><ArticleId IdType="pubmed">33095459</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesan P. NICE Guideline on Long COVID. Lancet Respir. Med. 2021;9:129. doi: 10.1016/S2213-2600(21)00031-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00031-X</ArticleId><ArticleId IdType="pmc">PMC7832375</ArticleId><ArticleId IdType="pubmed">33453162</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S., Barnett J., Brill S.E., Brown J.S., Denneny E.K., Hare S.S., Heightman M., Hillman T.E., Jacob J., Jarvis H.C., et al. &#x2018;Long-COVID&#x2019;: A Cross-Sectional Study of Persisting Symptoms, Biomarker and Imaging Abnormalities Following Hospitalisation for COVID-19. Thorax. 2021;76:396&#x2013;398. doi: 10.1136/thoraxjnl-2020-215818.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215818</ArticleId><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahboubi Mehrabani M., Karvandi M.S., Maafi P., Doroudian M. Neurological Complications Associated with COVID-19; Molecular Mechanisms and Therapeutic Approaches. Rev. Med. Virol. 2022;32:21&#x2013;44. doi: 10.1002/rmv.2334.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2334</ArticleId><ArticleId IdType="pmc">PMC9111040</ArticleId><ArticleId IdType="pubmed">35138001</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong T.L., Weitzer D.J. Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)&#x2014;A Systemic Review and Comparison of Clinical Presentation and Symptomatology. Medicina. 2021;57:418. doi: 10.3390/medicina57050418.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57050418</ArticleId><ArticleId IdType="pmc">PMC8145228</ArticleId><ArticleId IdType="pubmed">33925784</ArticleId></ArticleIdList></Reference><Reference><Citation>Orr&#xf9; G., Bertelloni D., Diolaiuti F., Mucci F., Di Giuseppe M., Biella M., Gemignani A., Ciacchini R., Conversano C. Long-COVID Syndrome? A Study on the Persistence of Neurological, Psychological and Physiological Symptoms. Healthcare. 2021;9:575. doi: 10.3390/healthcare9050575.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare9050575</ArticleId><ArticleId IdType="pmc">PMC8152255</ArticleId><ArticleId IdType="pubmed">34068009</ArticleId></ArticleIdList></Reference><Reference><Citation>Marx V. Scientists Set out to Connect the Dots on Long COVID. Nat. Methods. 2021;18:449&#x2013;453. doi: 10.1038/s41592-021-01145-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41592-021-01145-z</ArticleId><ArticleId IdType="pmc">PMC8081406</ArticleId><ArticleId IdType="pubmed">33911230</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold D.T., Hamilton F.W., Milne A., Morley A.J., Viner J., Attwood M., Noel A., Gunning S., Hatrick J., Hamilton S., et al. Patient Outcomes after Hospitalisation with COVID-19 and Implications for Follow-up: Results from a Prospective UK Cohort. Thorax. 2021;76:399&#x2013;401. doi: 10.1136/thoraxjnl-2020-216086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216086</ArticleId><ArticleId IdType="pmc">PMC7716340</ArticleId><ArticleId IdType="pubmed">33273026</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F., for the Gemelli Against COVID-19 Post-Acute Care Study Group Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324:603. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C., Laurent E., Lemaignen A., Beaufils E., Bourbao-Tournois C., Laribi S., Flament T., Ferreira-Maldent N., Bruy&#xe8;re F., Stefic K., et al. Follow-up of Adults with Noncritical COVID-19 Two Months after Symptom Onset. Clin. Microbiol. Infect. 2021;27:258&#x2013;263. doi: 10.1016/j.cmi.2020.09.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.052</ArticleId><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra V., Flanders S.A., O&#x2019;Malley M., Malani A.N., Prescott H.C. Sixty-Day Outcomes Among Patients Hospitalized With COVID-19. Ann. Intern. Med. 2021;174:576&#x2013;578. doi: 10.7326/M20-5661.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-5661</ArticleId><ArticleId IdType="pmc">PMC7707210</ArticleId><ArticleId IdType="pubmed">33175566</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai L.-L., Wang X., Jiang T.-C., Li P.-F., Wang Y., Wu S.-J., Jia L.-Q., Liu M., An L., Cheng Z. Anxiety and Depressive Symptoms among COVID-19 Patients in Jianghan Fangcang Shelter Hospital in Wuhan, China. PLoS ONE. 2020;15:e0238416. doi: 10.1371/journal.pone.0238416.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0238416</ArticleId><ArticleId IdType="pmc">PMC7454940</ArticleId><ArticleId IdType="pubmed">32857826</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re&#x2019;em Y., Redfield S., Austin J.P., Akrami A. Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact. eClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera J.A., Yang D., Lewis A., Patel P., Medicherla C., Arena V., Fang T., Andino A., Snyder T., Madhavan M., et al. A Prospective Study of Long-Term Outcomes among Hospitalized COVID-19 Patients with and without Neurological Complications. J. Neurol. Sci. 2021;426:117486. doi: 10.1016/j.jns.2021.117486.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2021.117486</ArticleId><ArticleId IdType="pmc">PMC8113108</ArticleId><ArticleId IdType="pubmed">34000678</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera J.A., Yang D., Medicherla C., Baskharoun S., Bauman K., Bell L., Bhagat D., Bondi S., Chervinsky A., Dygert L., et al. Trajectories of Neurologic Recovery 12 Months After Hospitalization for COVID-19: A Prospective Longitudinal Study. Neurology. 2022;99:e33&#x2013;e45. doi: 10.1212/WNL.0000000000200356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000200356</ArticleId><ArticleId IdType="pmc">PMC9259089</ArticleId><ArticleId IdType="pubmed">35314503</ArticleId></ArticleIdList></Reference><Reference><Citation>Go&#xeb;rtz Y.M.J., Van Herck M., Delbressine J.M., Vaes A.W., Meys R., Machado F.V.C., Houben-Wilke S., Burtin C., Posthuma R., Franssen F.M.E., et al. Persistent Symptoms 3 Months after a SARS-CoV-2 Infection: The Post-COVID-19 Syndrome? ERJ Open Res. 2020;6:00542&#x2013;02020. doi: 10.1183/23120541.00542-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00542-2020</ArticleId><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin S.J., McIvor C., Whyatt G., Adams A., Harvey O., McLean L., Walshaw C., Kemp S., Corrado J., Singh R., et al. Postdischarge Symptoms and Rehabilitation Needs in Survivors of COVID-19 Infection: A Cross-sectional Evaluation. J. Med. Virol. 2021;93:1013&#x2013;1022. doi: 10.1002/jmv.26368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26368</ArticleId><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., Kang L., Guo L., Liu M., Zhou X., et al. 6-Month Consequences of COVID-19 in Patients Discharged from Hospital: A Cohort Study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-P&#xe9;rez O., Merino E., Leon-Ramirez J.-M., Andres M., Ramos J.M., Arenas-Jim&#xe9;nez J., Asensio S., Sanchez R., Ruiz-Torregrosa P., Galan I., et al. Post-Acute COVID-19 Syndrome. Incidence and Risk Factors: A Mediterranean Cohort Study. J. Infect. 2021;82:378&#x2013;383. doi: 10.1016/j.jinf.2021.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.01.004</ArticleId><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen M.S., Kristiansen M.F., Hanusson K.D., Danielsen M.E., &#xe1; Steig B., Gaini S., Str&#xf8;m M., Weihe P. Long COVID in the Faroe Islands: A Longitudinal Study Among Nonhospitalized Patients. Clin. Infect. Dis. 2021;73:e4058&#x2013;e4063. doi: 10.1093/cid/ciaa1792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1792</ArticleId><ArticleId IdType="pmc">PMC7799340</ArticleId><ArticleId IdType="pubmed">33252665</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilotto A., Cristillo V., Cotti Piccinelli S., Zoppi N., Bonzi G., Sattin D., Schiavolin S., Raggi A., Canale A., Gipponi S., et al. Long-Term Neurological Manifestations of COVID-19: Prevalence and Predictive Factors. Neurol. Sci. 2021;42:4903&#x2013;4907. doi: 10.1007/s10072-021-05586-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-021-05586-4</ArticleId><ArticleId IdType="pmc">PMC8439956</ArticleId><ArticleId IdType="pubmed">34523082</ArticleId></ArticleIdList></Reference><Reference><Citation>Schweitzer F., Goereci Y., Franke C., Silling S., B&#xf6;sl F., Maier F., Heger E., Deiman B., Pr&#xfc;ss H., Onur O.A., et al. Cerebrospinal Fluid Analysis Post&#x2013;COVID-19 Is Not Suggestive of Persistent Central Nervous System Infection. Ann. Neurol. 2022;91:150&#x2013;157. doi: 10.1002/ana.26262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26262</ArticleId><ArticleId IdType="pmc">PMC8653324</ArticleId><ArticleId IdType="pubmed">34724243</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomasoni D., Bai F., Castoldi R., Barbanotti D., Falcinella C., Mul&#xe8; G., Mondatore D., Tavelli A., Vegni E., Marchetti G., et al. Anxiety and Depression Symptoms after Virological Clearance of COVID-19: A Cross-sectional Study in Milan, Italy. J. Med. Virol. 2021;93:1175&#x2013;1179. doi: 10.1002/jmv.26459.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26459</ArticleId><ArticleId IdType="pmc">PMC7461061</ArticleId><ArticleId IdType="pubmed">32841387</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Dyer A.H., Jones K., Dunne J., Mooney A., Gaffney F., O&#x2019;Connor L., Leavy D., O&#x2019;Brien K., Dowds J., et al. Persistent Fatigue Following SARS-CoV-2 Infection Is Common and Independent of Severity of Initial Infection. PLoS ONE. 2020;15:e0240784. doi: 10.1371/journal.pone.0240784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0240784</ArticleId><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Dowds J., O&#x2019;Brien K., Sheill G., Dyer A.H., O&#x2019;Kelly B., Hynes J.P., Mooney A., Dunne J., Ni Cheallaigh C., et al. Persistent Poor Health after COVID-19 Is Not Associated with Respiratory Complications or Initial Disease Severity. Ann. ATS. 2021;18:997&#x2013;1003. doi: 10.1513/AnnalsATS.202009-1175OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.202009-1175OC</ArticleId><ArticleId IdType="pmc">PMC8456724</ArticleId><ArticleId IdType="pubmed">33413026</ArticleId></ArticleIdList></Reference><Reference><Citation>Voruz P., Cionca A., Jacot de Alc&#xe2;ntara I., Nuber-Champier A., Allali G., Benzakour L., Thomasson M., Lalive P.H., L&#xf6;vblad K.-O., Braillard O., et al. Functional Connectivity Underlying Cognitive and Psychiatric Symptoms in Post-COVID-19 Syndrome: Is Anosognosia a Key Determinant? Brain Commun. 2022;4:fcac057. doi: 10.1093/braincomms/fcac057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcac057</ArticleId><ArticleId IdType="pmc">PMC8956133</ArticleId><ArticleId IdType="pubmed">35350554</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdolahi S., Hosseini M., Rezaei R., Mohebbi S.R., Rostami-Nejad M., Mojarad E.N., Mirjalali H., Yadegar A., Asadzadeh Aghdaei H., Zali M.R., et al. Evaluation of MiR-200c-3p and MiR-421-5p Levels during Immune Responses in the Admitted and Recovered COVID-19 Subjects. Infect. Genet. Evol. 2022;98:105207. doi: 10.1016/j.meegid.2022.105207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2022.105207</ArticleId><ArticleId IdType="pmc">PMC8730736</ArticleId><ArticleId IdType="pubmed">34999004</ArticleId></ArticleIdList></Reference><Reference><Citation>Akula S.M., Bolin P., Cook P.P. Cellular MiR-150-5p May Have a Crucial Role to Play in the Biology of SARS-CoV-2 Infection by Regulating Nsp10 Gene. RNA Biol. 2022;19:1&#x2013;11. doi: 10.1080/15476286.2021.2010959.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15476286.2021.2010959</ArticleId><ArticleId IdType="pmc">PMC8786335</ArticleId><ArticleId IdType="pubmed">34904915</ArticleId></ArticleIdList></Reference><Reference><Citation>Centa A., Fonseca A.S., da Silva Ferreira S.G., Azevedo M.L.V., de Paula C.B.V., Nagashima S., Machado-Souza C., dos Santos Miggiolaro A.F.R., Pellegrino Baena C., de Noronha L., et al. Deregulated MiRNA Expression Is Associated with Endothelial Dysfunction in Post-Mortem Lung Biopsies of COVID-19 Patients. Am. J. Physiol. -Lung Cell. Mol. Physiol. 2021;320:L405&#x2013;L412. doi: 10.1152/ajplung.00457.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00457.2020</ArticleId><ArticleId IdType="pmc">PMC7938642</ArticleId><ArticleId IdType="pubmed">33651636</ArticleId></ArticleIdList></Reference><Reference><Citation>Donyavi T., Bokharaei-Salim F., Baghi H.B., Khanaliha K., Alaei Janat-Makan M., Karimi B., Sadri Nahand J., Mirzaei H., Khatami A., Garshasbi S., et al. Acute and Post-Acute Phase of COVID-19: Analyzing Expression Patterns of MiRNA-29a-3p, 146a-3p, 155&#x2013;5p, and Let-7b-3p in PBMC. Int. Immunopharmacol. 2021;97:107641. doi: 10.1016/j.intimp.2021.107641.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2021.107641</ArticleId><ArticleId IdType="pmc">PMC8023203</ArticleId><ArticleId IdType="pubmed">33895478</ArticleId></ArticleIdList></Reference><Reference><Citation>Eichmeier A., Kiss T., Kocanova M., Hakalova E., Spetik M., Cechova J., Tichy B. Conserved MicroRNAs in Human Nasopharynx Tissue Samples from Swabs Are Differentially Expressed in Response to SARS-CoV-2. Genes. 2022;13:348. doi: 10.3390/genes13020348.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes13020348</ArticleId><ArticleId IdType="pmc">PMC8871708</ArticleId><ArticleId IdType="pubmed">35205390</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg A., Seeliger B., Derda A.A., Xiao K., Gietz A., Scherf K., Sonnenschein K., Pink I., Hoeper M.M., Welte T., et al. Circulating Cardiovascular microRNAs in Critically Ill COVID-19 Patients. Eur. J. Heart Fail. 2021;23:468&#x2013;475. doi: 10.1002/ejhf.2096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.2096</ArticleId><ArticleId IdType="pmc">PMC8014268</ArticleId><ArticleId IdType="pubmed">33421274</ArticleId></ArticleIdList></Reference><Reference><Citation>Giuliani A., Matacchione G., Ramini D., Di Rosa M., Bonfigli A.R., Sabbatinelli J., Monsurr&#xf2; V., Recchioni R., Marcheselli F., Marchegiani F., et al. Circulating MiR-320b and MiR-483-5p Levels Are Associated with COVID-19 in-Hospital Mortality. Mech. Ageing Dev. 2022;202:111636. doi: 10.1016/j.mad.2022.111636.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mad.2022.111636</ArticleId><ArticleId IdType="pmc">PMC8809668</ArticleId><ArticleId IdType="pubmed">35122770</ArticleId></ArticleIdList></Reference><Reference><Citation>De GONZALO-CALVO D., Ben&#xed;tez I.D., Pinilla L., Carratal&#xe1; A., Moncus&#xed;-Moix A., Gort-Paniello C., Molinero M., Gonz&#xe1;lez J., Torres G., Bernal M., et al. Circulating MicroRNA Profiles Predict the Severity of COVID-19 in Hospitalized Patients. Transl. Res. 2021;236:147&#x2013;159. doi: 10.1016/j.trsl.2021.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2021.05.004</ArticleId><ArticleId IdType="pmc">PMC8149473</ArticleId><ArticleId IdType="pubmed">34048985</ArticleId></ArticleIdList></Reference><Reference><Citation>Grehl C., Schulthei&#xdf; C., Hoffmann K., Binder M., Altmann T., Grosse I., Kuhlmann M. Detection of SARS-CoV-2 Derived Small RNAs and Changes in Circulating Small RNAs Associated with COVID-19. Viruses. 2021;13:1593. doi: 10.3390/v13081593.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13081593</ArticleId><ArticleId IdType="pmc">PMC8402885</ArticleId><ArticleId IdType="pubmed">34452458</ArticleId></ArticleIdList></Reference><Reference><Citation>Haroun R.A.-H., Osman W.H., Amin R.E., Hassan A.K., Abo-Shanab W.S., Eessa A.M. Circulating Plasma MiR-155 Is a Potential Biomarker for the Detection of SARS-CoV-2 Infection. Pathology. 2022;54:104&#x2013;110. doi: 10.1016/j.pathol.2021.09.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pathol.2021.09.006</ArticleId><ArticleId IdType="pmc">PMC8570980</ArticleId><ArticleId IdType="pubmed">34838331</ArticleId></ArticleIdList></Reference><Reference><Citation>Fayyad-Kazan M., Makki R., Skafi N., El Homsi M., Hamade A., El Majzoub R., Hamade E., Fayyad-Kazan H., Badran B. Circulating MiRNAs: Potential Diagnostic Role for Coronavirus Disease 2019 (COVID-19) Infect. Genet. Evol. 2021;94:105020. doi: 10.1016/j.meegid.2021.105020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2021.105020</ArticleId><ArticleId IdType="pmc">PMC8325559</ArticleId><ArticleId IdType="pubmed">34343725</ArticleId></ArticleIdList></Reference><Reference><Citation>Keikha R., Hashemi-Shahri S.M., Jebali A. The MiRNA Neuroinflammatory Biomarkers in COVID-19 Patients with Different Severity of Illness. Neurolog&#xed;a. 2021 doi: 10.1016/j.nrl.2021.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nrl.2021.06.005</ArticleId><ArticleId IdType="pmc">PMC10278372</ArticleId><ArticleId IdType="pubmed">37344097</ArticleId></ArticleIdList></Reference><Reference><Citation>Keikha R., Hashemi-Shahri S.M., Jebali A. The Relative Expression of MiR-31, MiR-29, MiR-126, and MiR-17 and Their MRNA Targets in the Serum of COVID-19 Patients with Different Grades during Hospitalization. Eur. J. Med. Res. 2021;26:75. doi: 10.1186/s40001-021-00544-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40001-021-00544-4</ArticleId><ArticleId IdType="pmc">PMC8276226</ArticleId><ArticleId IdType="pubmed">34256840</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X., Wen Y.-Z., Huang Z.-L., Shen X., Wang J.-H., Luo Y.-H., Chen W.-X., Lun Z.-R., Li H.-B., Qu L.-H., et al. SARS-CoV-2 Causes a Significant Stress Response Mediated by Small RNAs in the Blood of COVID-19 Patients. Mol. Ther. -Nucleic Acids. 2022;27:751&#x2013;762. doi: 10.1016/j.omtn.2021.12.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtn.2021.12.034</ArticleId><ArticleId IdType="pmc">PMC8719421</ArticleId><ArticleId IdType="pubmed">35003892</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald J.T., Enguita F.J., Taylor D., Griffin R.J., Priebe W., Emmett M.R., Sajadi M.M., Harris A.D., Clement J., Dybas J.M., et al. The Great Deceiver: MiR-2392&#x2019;s Hidden Role in Driving SARS-CoV-2 Infection. bioRxiv. 2021 doi: 10.1101/2021.04.23.441024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.04.23.441024</ArticleId><ArticleId IdType="pmc">PMC8481092</ArticleId><ArticleId IdType="pubmed">34624208</ArticleId></ArticleIdList></Reference><Reference><Citation>De Souza Nicoletti A., Visacri M.B., da Ronda C.R.d.S.C., Vasconcelos P.E.d.N.S., Quintanilha J.C.F., de Souza R.N., Ventura D.d.S., Eguti A., Silva L.F.d.S., Perroud Junior M.W., et al. Differentially Expressed Plasmatic MicroRNAs in Brazilian Patients with Coronavirus Disease 2019 (COVID-19): Preliminary Results. Mol. Biol. Rep. 2022;49:6931&#x2013;6943. doi: 10.1007/s11033-022-07338-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-022-07338-9</ArticleId><ArticleId IdType="pmc">PMC8929466</ArticleId><ArticleId IdType="pubmed">35301654</ArticleId></ArticleIdList></Reference><Reference><Citation>Parray A., Mir F.A., Doudin A., Iskandarani A., Danjuma I.M.M., Kuni R.A.T., Abdelmajid A., Abdelhafez I., Arif R., Mulhim M., et al. SnoRNAs and MiRNAs Networks Underlying COVID-19 Disease Severity. Vaccines. 2021;9:1056. doi: 10.3390/vaccines9101056.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9101056</ArticleId><ArticleId IdType="pmc">PMC8538251</ArticleId><ArticleId IdType="pubmed">34696164</ArticleId></ArticleIdList></Reference><Reference><Citation>Pimenta R., Viana N., dos Santos G., Candido P., Guimaraes V., Romao P., Silva I., de Camargo J., Hatanaka D., Queiroz P., et al. MiR-200c-3p Expression May Be Associated with Worsening of the Clinical Course of Patients with COVID-19. Mol. Biol. Res. Commun. 2021;10:141. doi: 10.22099/mbrc.2021.40555.1631.</Citation><ArticleIdList><ArticleId IdType="doi">10.22099/mbrc.2021.40555.1631</ArticleId><ArticleId IdType="pmc">PMC8340313</ArticleId><ArticleId IdType="pubmed">34476267</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabbatinelli J., Giuliani A., Matacchione G., Latini S., Laprovitera N., Pomponio G., Ferrarini A., Svegliati Baroni S., Pavani M., Moretti M., et al. Decreased Serum Levels of the Inflammaging Marker MiR-146a Are Associated with Clinical Non-Response to Tocilizumab in COVID-19 Patients. Mech. Ageing Dev. 2021;193:111413. doi: 10.1016/j.mad.2020.111413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mad.2020.111413</ArticleId><ArticleId IdType="pmc">PMC7722494</ArticleId><ArticleId IdType="pubmed">33307107</ArticleId></ArticleIdList></Reference><Reference><Citation>Saulle I., Garziano M., Fenizia C., Cappelletti G., Parisi F., Clerici M., Cetin I., Savasi V., Biasin M. MiRNA Profiling in Plasma and Placenta of SARS-CoV-2-Infected Pregnant Women. Cells. 2021;10:1788. doi: 10.3390/cells10071788.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10071788</ArticleId><ArticleId IdType="pmc">PMC8305278</ArticleId><ArticleId IdType="pubmed">34359957</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson J.C., Kealy D., James S.R., Plowman T., Newling K., Jagger C., Filbey K., Mann E.R., Konkel J.E., Menon M., et al. Integrated MiRNA/Cytokine/Chemokine Profiling Reveals Severity-Associated Step Changes and Principal Correlates of Fatality in COVID-19. iScience. 2022;25:103672. doi: 10.1016/j.isci.2021.103672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2021.103672</ArticleId><ArticleId IdType="pmc">PMC8686203</ArticleId><ArticleId IdType="pubmed">34957382</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu W., Choi E.-J., Wang B., Zhang K., Adam A., Huang G., Tunkle L., Huang P., Goru R., Imirowicz I., et al. Changes of Small Non-Coding RNAs by Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Front. Mol. Biosci. 2022;9:821137. doi: 10.3389/fmolb.2022.821137.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2022.821137</ArticleId><ArticleId IdType="pmc">PMC8905365</ArticleId><ArticleId IdType="pubmed">35281271</ArticleId></ArticleIdList></Reference><Reference><Citation>Olivieri F., Prattichizzo F., Giuliani A., Matacchione G., Rippo M.R., Sabbatinelli J., Bonaf&#xe8; M. MiR-21 and MiR-146a: The MicroRNAs of Inflammaging and Age-Related Diseases. Ageing Res. Rev. 2021;70:101374. doi: 10.1016/j.arr.2021.101374.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2021.101374</ArticleId><ArticleId IdType="pubmed">34082077</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang H., Gao Y., Li Z., Miao Y., Huang Z., Liu X., Xie L., Li H., Wen W., Zheng Y., et al. The Noncoding and Coding Transcriptional Landscape of the Peripheral Immune Response in Patients with COVID-19. Clin. Transl. Med. 2020;10:e200. doi: 10.1002/ctm2.200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ctm2.200</ArticleId><ArticleId IdType="pmc">PMC7548099</ArticleId><ArticleId IdType="pubmed">33135345</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Wu R., Liu Z., Fan J., Yang H. Enforced Expression of MicroRNA-21 Influences the Replication of Varicella-Zoster Virus by Triggering Signal Transducer and Activator of Transcription 3. Exp. Ther. Med. 2014;7:1291&#x2013;1296. doi: 10.3892/etm.2014.1588.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2014.1588</ArticleId><ArticleId IdType="pmc">PMC3991484</ArticleId><ArticleId IdType="pubmed">24940427</ArticleId></ArticleIdList></Reference><Reference><Citation>De Melo P., Pineros Alvarez A.R., Ye X., Blackman A., Alves-Filho J.C., Medeiros A.I., Rathmell J., Pua H., Serezani C.H. Macrophage-Derived MicroRNA-21 Drives Overwhelming Glycolytic and Inflammatory Response during Sepsis via Repression of the PGE2/IL-10 Axis. J. Immunol. 2021;207:902&#x2013;912. doi: 10.4049/jimmunol.2001251.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.2001251</ArticleId><ArticleId IdType="pmc">PMC8323968</ArticleId><ArticleId IdType="pubmed">34301845</ArticleId></ArticleIdList></Reference><Reference><Citation>Hori N., Narita M., Yamashita A., Horiuchi H., Hamada Y., Kondo T., Watanabe M., Igarashi K., Kawata M., Shibasaki M., et al. Changes in the Expression of IL-6-Mediated MicroRNAs in the Dorsal Root Ganglion under Neuropathic Pain in Mice: Changes in Micrornas Under Neuropathic Pain. Synapse. 2016;70:317&#x2013;324. doi: 10.1002/syn.21902.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/syn.21902</ArticleId><ArticleId IdType="pubmed">26990296</ArticleId></ArticleIdList></Reference><Reference><Citation>Leinders M., &#xdc;&#xe7;eyler N., Thomann A., Sommer C. Aberrant MicroRNA Expression in Patients with Painful Peripheral Neuropathies. J. Neurol. Sci. 2017;380:242&#x2013;249. doi: 10.1016/j.jns.2017.07.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2017.07.041</ArticleId><ArticleId IdType="pubmed">28870579</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinhold A.K., Krug S.M., Salvador E., Sauer R.S., Karl-Sch&#xf6;ller F., Malcangio M., Sommer C., Rittner H.L. MicroRNA-21-5p Functions via RECK/MMP9 as a Proalgesic Regulator of the Blood Nerve Barrier in Nerve Injury. Ann. NY Acad. Sci. 2022;1515:184&#x2013;195. doi: 10.1111/nyas.14816.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nyas.14816</ArticleId><ArticleId IdType="pubmed">35716075</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu M., Mo L., Li J., Liang H., Zhu W., Zheng X., Duan X., Xu W. Effects of MiR-150-5p on the Growth and SOCS1 Expression of Rheumatoid Arthritis Synovial Fibroblasts. Clin. Rheumatol. 2020;39:909&#x2013;917. doi: 10.1007/s10067-019-04894-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-019-04894-7</ArticleId><ArticleId IdType="pubmed">31879859</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald J.T., Enguita F.J., Taylor D., Griffin R.J., Priebe W., Emmett M.R., Sajadi M.M., Harris A.D., Clement J., Dybas J.M., et al. Role of MiR-2392 in Driving SARS-CoV-2 Infection. Cell Rep. 2021;37:109839. doi: 10.1016/j.celrep.2021.109839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109839</ArticleId><ArticleId IdType="pmc">PMC8481092</ArticleId><ArticleId IdType="pubmed">34624208</ArticleId></ArticleIdList></Reference><Reference><Citation>Maucher D., Schmidt B., Schumann J. Loss of Endothelial Barrier Function in the Inflammatory Setting: Indication for a Cytokine-Mediated Post-Transcriptional Mechanism by Virtue of Upregulation of MiRNAs MiR-29a-3p, MiR-29b-3p, and MiR-155-5p. Cells. 2021;10:2843. doi: 10.3390/cells10112843.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10112843</ArticleId><ArticleId IdType="pmc">PMC8616298</ArticleId><ArticleId IdType="pubmed">34831066</ArticleId></ArticleIdList></Reference><Reference><Citation>Magenta A., D&#x2019;Agostino M., Sileno S., Di Vito L., Uras C., Abeni D., Martino F., Barill&#xe0; F., Madonna S., Albanesi C., et al. The Oxidative Stress-Induced MiR-200c Is Upregulated in Psoriasis and Correlates with Disease Severity and Determinants of Cardiovascular Risk. Oxidat. Med. Cell. Longev. 2019;2019:1&#x2013;12. doi: 10.1155/2019/8061901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/8061901</ArticleId><ArticleId IdType="pmc">PMC6939435</ArticleId><ArticleId IdType="pubmed">31929856</ArticleId></ArticleIdList></Reference><Reference><Citation>Nersisyan S., Shkurnikov M., Turchinovich A., Knyazev E., Tonevitsky A. Integrative Analysis of MiRNA and MRNA Sequencing Data Reveals Potential Regulatory Mechanisms of ACE2 and TMPRSS2. PLoS ONE. 2020;15:e0235987. doi: 10.1371/journal.pone.0235987.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0235987</ArticleId><ArticleId IdType="pmc">PMC7390267</ArticleId><ArticleId IdType="pubmed">32726325</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng H.-Y., Xu M., Yang C.-X., Tian R.-R., Zhang M., Li J.-J., Wang X.-C., Ding Z.-L., Li G.-M., Li X.-L., et al. Longitudinal Transcriptome Analyses Show Robust T Cell Immunity during Recovery from COVID-19. Sig Transduct Target. 2020;5:294. doi: 10.1038/s41392-020-00457-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-00457-4</ArticleId><ArticleId IdType="pmc">PMC7758413</ArticleId><ArticleId IdType="pubmed">33361761</ArticleId></ArticleIdList></Reference><Reference><Citation>Shakola F., Suri P., Ruggiu M. Splicing Regulation of Pro-Inflammatory Cytokines and Chemokines: At the Interface of the Neuroendocrine and Immune Systems. Biomolecules. 2015;5:2073&#x2013;2100. doi: 10.3390/biom5032073.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom5032073</ArticleId><ArticleId IdType="pmc">PMC4598789</ArticleId><ArticleId IdType="pubmed">26371053</ArticleId></ArticleIdList></Reference><Reference><Citation>Abaurrea A., Araujo A.M., Caffarel M.M. The Role of the IL-6 Cytokine Family in Epithelial&#x2013;Mesenchymal Plasticity in Cancer Progression. Int. J. Mol. Sci. 2021;22:8334. doi: 10.3390/ijms22158334.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22158334</ArticleId><ArticleId IdType="pmc">PMC8347315</ArticleId><ArticleId IdType="pubmed">34361105</ArticleId></ArticleIdList></Reference><Reference><Citation>Deverman B.E., Patterson P.H. Cytokines and CNS Development. Neuron. 2009;64:61&#x2013;78. doi: 10.1016/j.neuron.2009.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2009.09.002</ArticleId><ArticleId IdType="pubmed">19840550</ArticleId></ArticleIdList></Reference><Reference><Citation>Kany S., Vollrath J.T., Relja B. Cytokines in Inflammatory Disease. Int. J. Mol. Sci. 2019;20:6008. doi: 10.3390/ijms20236008.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20236008</ArticleId><ArticleId IdType="pmc">PMC6929211</ArticleId><ArticleId IdType="pubmed">31795299</ArticleId></ArticleIdList></Reference><Reference><Citation>Gangadharan V., Kuner R. Pain Hypersensitivity Mechanisms at a Glance. Dis. Model. Mech. 2013;6:889&#x2013;895. doi: 10.1242/dmm.011502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.011502</ArticleId><ArticleId IdType="pmc">PMC3701208</ArticleId><ArticleId IdType="pubmed">23828645</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasrija R., Naime M. The Deregulated Immune Reaction and Cytokines Release Storm (CRS) in COVID-19 Disease. Int. Immunopharmacol. 2021;90:107225. doi: 10.1016/j.intimp.2020.107225.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2020.107225</ArticleId><ArticleId IdType="pmc">PMC7691139</ArticleId><ArticleId IdType="pubmed">33302033</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuyama T., Kubli S.P., Yoshinaga S.K., Pfeffer K., Mak T.W. An Aberrant STAT Pathway Is Central to COVID-19. Cell Death Differ. 2020;27:3209&#x2013;3225. doi: 10.1038/s41418-020-00633-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-020-00633-7</ArticleId><ArticleId IdType="pmc">PMC7545020</ArticleId><ArticleId IdType="pubmed">33037393</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray P.J. The JAK-STAT Signaling Pathway: Input and Output Integration. J. Immunol. 2007;178:2623&#x2013;2629. doi: 10.4049/jimmunol.178.5.2623.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.178.5.2623</ArticleId><ArticleId IdType="pubmed">17312100</ArticleId></ArticleIdList></Reference><Reference><Citation>Garbers C., Aparicio-Siegmund S., Rose-John S. The IL-6/Gp130/STAT3 Signaling Axis: Recent Advances towards Specific Inhibition. Curr. Opin. Immunol. 2015;34:75&#x2013;82. doi: 10.1016/j.coi.2015.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2015.02.008</ArticleId><ArticleId IdType="pubmed">25749511</ArticleId></ArticleIdList></Reference><Reference><Citation>Montero P., Milara J., Roger I., Cortijo J. Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms. Int. J. Mol. Sci. 2021;22:6211. doi: 10.3390/ijms22126211.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22126211</ArticleId><ArticleId IdType="pmc">PMC8226626</ArticleId><ArticleId IdType="pubmed">34207510</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirano T. IL-6 in Inflammation, Autoimmunity and Cancer. Int. Immunol. 2021;33:127&#x2013;148. doi: 10.1093/intimm/dxaa078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/dxaa078</ArticleId><ArticleId IdType="pmc">PMC7799025</ArticleId><ArticleId IdType="pubmed">33337480</ArticleId></ArticleIdList></Reference><Reference><Citation>Jafarzadeh A., Nemati M., Jafarzadeh S. Contribution of STAT3 to the Pathogenesis of COVID-19. Microb. Pathog. 2021;154:104836. doi: 10.1016/j.micpath.2021.104836.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micpath.2021.104836</ArticleId><ArticleId IdType="pmc">PMC7937040</ArticleId><ArticleId IdType="pubmed">33691172</ArticleId></ArticleIdList></Reference><Reference><Citation>Horita M., Farquharson C., Stephen L.A. The Role of MiR-29 Family in Disease. J. Cell Biochem. 2021;122:696&#x2013;715. doi: 10.1002/jcb.29896.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.29896</ArticleId><ArticleId IdType="pmc">PMC8603934</ArticleId><ArticleId IdType="pubmed">33529442</ArticleId></ArticleIdList></Reference><Reference><Citation>Aloi M.S., Prater K.E., Sopher B., Davidson S., Jayadev S., Garden G.A. The Pro-inflammatory microRNA miR-155 Influences Fibrillar &#x3b2;-Amyloid 1-42 Catabolism by Microglia. Glia. 2021;69:1736&#x2013;1748. doi: 10.1002/glia.23988.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23988</ArticleId><ArticleId IdType="pmc">PMC9098129</ArticleId><ArticleId IdType="pubmed">33694209</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan Y., Yang J., Xiang K., Tan Q., Guo Q. Suppression of MicroRNA-155 Attenuates Neuropathic Pain by Regulating SOCS1 Signalling Pathway. Neurochem. Res. 2015;40:550&#x2013;560. doi: 10.1007/s11064-014-1500-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-014-1500-2</ArticleId><ArticleId IdType="pubmed">25488154</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander W.S., Hilton D.J. The Role of Suppressors of Cytokine Signaling (SOCS) Proteins in Regulation of the Immune Response. Annu. Rev. Immunol. 2004;22:503&#x2013;529. doi: 10.1146/annurev.immunol.22.091003.090312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.immunol.22.091003.090312</ArticleId><ArticleId IdType="pubmed">15032587</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann J., Machado D., Terrier O., Pouzol S., Messaoudi M., Basualdo W., Esp&#xed;nola E.E., Guillen R.M., Rosa-Calatrava M., Picot V., et al. Viral and Bacterial Co-Infection in Severe Pneumonia Triggers Innate Immune Responses and Specifically Enhances IP-10: A Translational Study. Sci. Rep. 2016;6:38532. doi: 10.1038/srep38532.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep38532</ArticleId><ArticleId IdType="pmc">PMC5138590</ArticleId><ArticleId IdType="pubmed">27922126</ArticleId></ArticleIdList></Reference><Reference><Citation>Magenta A., Sileno S., D&#x2019;Agostino M., Persiani F., Beji S., Paolini A., Camilli D., Platone A., Capogrossi M.C., Furgiuele S. Atherosclerotic Plaque Instability in Carotid Arteries: MiR-200c as a Promising Biomarker. Clin. Sci. 2018;132:2423&#x2013;2436. doi: 10.1042/CS20180684.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20180684</ArticleId><ArticleId IdType="pubmed">30389857</ArticleId></ArticleIdList></Reference><Reference><Citation>Li F., Li S.-S., Chen H., Zhao J.-Z., Hao J., Liu J.-M., Zu X.-G., Cui W. MiR-320 Accelerates Chronic Heart Failure with Cardiac Fibrosis through Activation of the IL6/STAT3 Axis. Aging. 2021;13:22516&#x2013;22527. doi: 10.18632/aging.203562.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.203562</ArticleId><ArticleId IdType="pmc">PMC8507257</ArticleId><ArticleId IdType="pubmed">34582362</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X., Zhang A., Xiang J., Lv Y., Zhang X. MiR-451 Acts as a Suppressor of Angiogenesis in Hepatocellular Carcinoma by Targeting the IL-6R-STAT3 Pathway. Oncol. Rep. 2016;36:1385&#x2013;1392. doi: 10.3892/or.2016.4971.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/or.2016.4971</ArticleId><ArticleId IdType="pubmed">27461244</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinhold A., Rittner H. Barrier Function in the Peripheral and Central Nervous System&#x2014;A Review. Pflugers Arch. -Eur. J. Physiol. 2017;469:123&#x2013;134. doi: 10.1007/s00424-016-1920-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00424-016-1920-8</ArticleId><ArticleId IdType="pubmed">27957611</ArticleId></ArticleIdList></Reference><Reference><Citation>Richner M., Ferreira N., Dudele A., Jensen T.S., Vaegter C.B., Gon&#xe7;alves N.P. Functional and Structural Changes of the Blood-Nerve-Barrier in Diabetic Neuropathy. Front. Neurosci. 2019;12:1038. doi: 10.3389/fnins.2018.01038.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.01038</ArticleId><ArticleId IdType="pmc">PMC6339909</ArticleId><ArticleId IdType="pubmed">30692907</ArticleId></ArticleIdList></Reference><Reference><Citation>Vafadari B., Salamian A., Kaczmarek L. MMP-9 in Translation: From Molecule to Brain Physiology, Pathology, and Therapy. J. Neurochem. 2016;139:91&#x2013;114. doi: 10.1111/jnc.13415.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13415</ArticleId><ArticleId IdType="pubmed">26525923</ArticleId></ArticleIdList></Reference><Reference><Citation>Demestre M., Wells G.M., Miller K.M., Smith K.J., Hughes R.A.C., Gearing A.J., Gregson N.A. Characterisation of Matrix Metalloproteinases and the Effects of a Broad-Spectrum Inhibitor (BB-1101) in Peripheral Nerve Regeneration. Neuroscience. 2004;124:767&#x2013;779. doi: 10.1016/j.neuroscience.2003.12.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2003.12.037</ArticleId><ArticleId IdType="pubmed">15026117</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L.-Y., Zheng H., Xiao H.-L., She Z.-J., Zhao S.-M., Chen Z.-L., Zhou G.-M. Comparison of Blood&#x2013;Nerve Barrier Disruption and Matrix Metalloprotease-9 Expression in Injured Central and Peripheral Nerves in Mice. Neurosci. Lett. 2008;434:155&#x2013;159. doi: 10.1016/j.neulet.2007.12.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2007.12.052</ArticleId><ArticleId IdType="pubmed">18243551</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabriely G., Wurdinger T., Kesari S., Esau C.C., Burchard J., Linsley P.S., Krichevsky A.M. MicroRNA 21 Promotes Glioma Invasion by Targeting Matrix Metalloproteinase Regulators. Mol. Cell Biol. 2008;28:5369&#x2013;5380. doi: 10.1128/MCB.00479-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00479-08</ArticleId><ArticleId IdType="pmc">PMC2519720</ArticleId><ArticleId IdType="pubmed">18591254</ArticleId></ArticleIdList></Reference><Reference><Citation>Nan Y., Guo L., Zhen Y., Wang L., Ren B., Chen X., Lu Y., Yu K., Zhong Y., Huang Q. MiRNA-451 Regulates the NF-&#x39a;B Signaling Pathway by Targeting IKK&#x3b2; to Inhibit Glioma Cell Growth. Cell Cycle. 2021;20:1967&#x2013;1977. doi: 10.1080/15384101.2021.1969496.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15384101.2021.1969496</ArticleId><ArticleId IdType="pmc">PMC8565813</ArticleId><ArticleId IdType="pubmed">34463194</ArticleId></ArticleIdList></Reference><Reference><Citation>Scholz J., Woolf C.J. The Neuropathic Pain Triad: Neurons, Immune Cells and Glia. Nat. Neurosci. 2007;10:1361&#x2013;1368. doi: 10.1038/nn1992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1992</ArticleId><ArticleId IdType="pubmed">17965656</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawasaki Y., Xu Z.-Z., Wang X., Park J.Y., Zhuang Z.-Y., Tan P.-H., Gao Y.-J., Roy K., Corfas G., Lo E.H., et al. Distinct Roles of Matrix Metalloproteases in the Early- and Late-Phase Development of Neuropathic Pain. Nat. Med. 2008;14:331&#x2013;336. doi: 10.1038/nm1723.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1723</ArticleId><ArticleId IdType="pmc">PMC2279180</ArticleId><ArticleId IdType="pubmed">18264108</ArticleId></ArticleIdList></Reference><Reference><Citation>Licursi V., Conte F., Fiscon G., Paci P. MIENTURNET: An Interactive Web Tool for MicroRNA-Target Enrichment and Network-Based Analysis. BMC Bioinform. 2019;20:545. doi: 10.1186/s12859-019-3105-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12859-019-3105-x</ArticleId><ArticleId IdType="pmc">PMC6829817</ArticleId><ArticleId IdType="pubmed">31684860</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>